Answers are grounded in this paper and cite their sources.
Randomized controlled trial improved psychosocial outcomes for neuro-oncology caregivers, indicating CARING's efficacy.
Background We developed CARING to support neuro-oncology caregivers. CARING includes eSNAP, a web-based tool to identify social support resources, and 8 weeks of individual phone-based non-clinical navigation focused on support identification and coping skills. This study aimed to evaluate the efficacy of CARING on caregiver and patient psychosocial outcomes. Methods We compared CARING to a waitlist control (WLC) in an RCT. Neuro-oncology patients and their caregivers were recruited from an National Cancer Institute (NCI)-designated comprehensive cancer center in Florida from February 2020 to June 2024. Eighty-one caregivers were assigned to CARING and 35 to WLC. All participants completed baseline measures including demographics and health data. Primary outcomes collected at 8 weeks were caregiver support and self-efficacy. Secondary outcomes were caregiver burden, personal gain, and caregiver and patient anxiety and depressive symptoms. General Linear Mixed Models examined changes in outcomes from baseline to 8 weeks by condition. Results No significant demographic differences existed between condition. CARING caregivers reported significantly lower ratings of stress/frustration compared to feeling in control/hope (F(1,92)=6.19, p=.015) at 8 weeks compared to WLC. There was a significant increase in personal gain (M=0.7, SD=2.5, t(63)=2.13, p=.037) and a marginally-significant increase in self-efficacy (M=1.6, SD=6.6, t(61)=1.88, p=.065) for CARING caregivers at 8 weeks. Although the intervention is targeted only at caregivers, patients of CARING caregivers reported marginally-significantly fewer depressive symptoms (F(1,51)=2.89, p=.096) at 8 weeks compared to WLC. Conclusion CARING decreases the ratio of negative to positive emotions and perceptions of personal gain in caregivers at 8-weeks, compared to WLC.
No takes yet. Share an insight, caveat, or question.
Reblin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: